You have 9 free searches left this month | for more free features.

City

Minneapolis (2)

Saint Louis (2)

Chicago (1)

Houston (1)

Nashville (1)

New York (1)

San Antonio (1)

Seattle (1)

Overall Status

Recruiting (1)

Suspended (1)

Withdrawn (1)

Sign in for free

Phase

phase 1 (3)

Sponsor

Fate Therapeutics (2)

Masonic Cancer Center, University of Minnesota (1)

Collaborator

Intervention

ft596 (3)

rituximab (3)

cyclophosphamide (2)

bendamustine (1)

doxorubicin (1)

fludarabine (1)

obinutuzumab (1)

prednisone (1)

vincristine (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

ft596

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Diffuse Large B Cell Lymphoma, Transformed Indolent Non-Hodgkin's Lymphoma, Follicular Lymphoma Trial (FT596, Cyclophosphamide,

Withdrawn

Diffuse Large B Cell Lymphoma
+4 more

FT596
+6 more

(no location specified)

Jun 28, 2023

NHL, Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis, Saint Louis (FT596, Rituximab)

Suspended

NHL
+3 more

FT596
Rituximab

Minneapolis, Minnesota
+1 more

Jan 31, 2023

Lymphoma, B-Cell, Chronic Lymphocytic Leukemia Trial in United States (FT596, Cyclophosphamide, Fludarabine)

Recruiting

Lymphoma, B-Cell
Chronic Lymphocytic Leukemia

FT596
+4 more

Chicago, Illinois
+8 more

Jun 21, 2022